QUICK ANSWER · AEO / GEO
An SSRI with Thai product registrations for depression-related indications and other product-specific approved uses; premature-ejaculation evidence remains off-label, with long persistence relevant to interactions and medicine changes.
ENTITY FACTS
What should readers identify first?
What remains unknown?
English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.
Read original excerpts (Thai / mixed language)
- หลักฐานการชะลอการหลั่งไม่เปลี่ยน fluoxetine ให้เป็นยาที่อนุมัติสำหรับ PE โดยอัตโนมัติ
- ผลต่อการหลั่งไม่ใช่หลักฐานเพิ่มความต้องการทางเพศ รักษาภาวะหย่อนสมรรถภาพทางเพศ หรือเพิ่มความพึงพอใจในทุกคน
- Prozac, fluoxetine generic, delayed-release formulation และสูตรร่วมกับ olanzapine มีฉลากและบริบทต่างกัน ไม่ควรถือว่าใช้แทนกันโดยไม่ตรวจผลิตภัณฑ์จริง
What limits these conclusions?
Insufficient data in the current dataset
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
FAQ · ANSWER ENGINE
Frequently asked questions
What is Fluoxetine?
Fluoxetine is described pharmacologically as Selective serotonin reuptake inhibitor (SSRI). An SSRI with Thai product registrations for depression-related indications and other product-specific approved uses; premature-ejaculation evidence remains off-label, with long persistence relevant to interactions and medicine changes.
Does Fluoxetine have strong evidence?
PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is Fluoxetine approved everywhere?
No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.